You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 1, January 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL NOTES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Adjuvant Hyperbaric Oxygen in Malignant External Otitis

Jefferson C. Davis, MD; George A. Gates, MD; Charles Lerner, MD; Merrit G. Davis, Jr, DO; Jon T. Mader, MD; Alan Dinesman, MD

Arch Otolaryngol Head Neck Surg. 1992;118(1):89-93.


Abstract

• Necrotizing invasive pseudomonal infection of the external auditory canal (malignant external otitis) is an uncommon but important disorder in the elderly. The high morbidity, and even mortality, of this disorder has been reduced by the early and intensive use of combination antipseudomonal antibiotics. However, in severely immunocompromised patients or in infection involving the base of the skull, multiple cranial nerves, or the meninges, conventional therapy has been prolonged, intensive, and relatively ineffective. We treated 16 patients with malignant external otitis with adjuvant hyperbaric oxygen therapy. In six patients, infection was in advanced stages, infections were recurrences after previous treatment, and repeated treatment with antipseudomonal antibiotics had failed. All 16 cases responded promptly when a 30-day course of hyperbaric oxygen was added to the antibiotic regimen, and all patients remained free of infection or neurologic deficit during 1 to 4 years of follow-up. No complications of this treatment modality were noted. Hyperbaric oxygen therapy reverses tissue hypoxia, which enhances phagocytic killing of aerobic microorganisms, and stimulates neomicroangiogenesis. In addition, hyperbaric oxygen augments the action of aminoglycoside antibiotics. Adjuvant hyperbaric oxygen therapy should be considered in advanced or recurrent cases of malignant external otitis.

(Arch Otolaryngol Head Neck Surg. 1992;118:89-93)



Author Affiliations

From the Departments of Hyperbaric Medicine (Drs J.C. Davis and M.G. Davis) and Medicine (Dr Lerner), Southwest Texas Methodist Hospital, the Department of Otolaryngology, Washington University School of Medicine, St Louis, Mo (Dr Gates), the Department of Medicine, University of Texas Medical Branch at Galveston (Dr Mader), and the Department of Otolaryngology, Northside Presbyterian Hospital, Albuquerque, NM (Dr Dinesman).


Footnotes

Accepted for publication May 9, 1991.

Deceased.

Reprint requests to the Department of Otolaryngology, Washington University School of Medicine, 517 S Euclid, Box 8115, St Louis, MO 63110 (Dr Gates).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hyperbaric oxygen: its uses, mechanisms of action and outcomes
Gill and Bell
QJM 2004;97:385-395.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.